Importance Research about population-level changes in the incidence and stage of head and neck cancer (HNC) associated with the COVID-19 pandemic is sparse. Objective To examine the change in localized vs advan
Head and neck cancers represent roughly 3–5% of the total new cancer cases. In the United States 40,000 new cases are observed each year. The male-to-female ratio is 3:1. While head-and-neck tumors were primarily tumors of older males, a significant increase of the incidence has been ...
Head and neck squamous cell carcinomas (HNSCCs) are an aggressive, genetically complex and difficult to treat group of cancers. In lieu of truly effective targeted therapies, surgery and radiotherapy represent the primary treatment options for most patients. But these treatments are associated with s...
This analysis includes 497 case-control pairs of the head and neck and oesophagus, as well as 443 additional controls. Circulating 25(OH)D3 were measured in pre-diagnostic samples and evaluated in relation to HNC and oesophagus cancer risk and post-diagnosis all-cause mortality. After ...
In the US, an estimated 60,000 new cases of head and neck cancers are diagnosed every year. These cancers arise from the mucosa of the upper aerodigestive tract, with the majority being squamous cell carcinoma. Subsites include oral cavity, oropharynx, h
Head and neck cancer that has come back or spread Learn more Treatment with ERBITUX and what to expect ERBITUX is an approved treatment for people with certain advanced colorectal and head and neck cancers. Knowing more about your treatment may help you feel more prepared. Here you'll find in...
Head and neck cancer is one of the most frequent malignancies, including cancers of the oral cavity, pharynx, larynx, paranasal sinuses, and nasal cavity [1]. There were more than 878,000 new cases of head and neck cancers in 2020 and approximately 445,000 deaths each year worldwide [2...
This study aimed to determine the incidence rates of refeeding phenomena (defined as a decline in p-phosphate) and refeeding syndrome (RFS; defined as development of clinical symptoms in addition to a decline in p-phosphate) in head and neck cancer patients, and to identify risk factors. ...
Head and neck squamous cell carcinoma (HNSCC) represents the sixth most common cancer worldwide.1 While the overall incidence of HNSCC, traditionally associated with tobacco or alcohol consumption, is declining, a subset of oropharyngeal cancers caused by infection with high-risk types of human papil...
1Department of Otolaryngology—Head and Neck Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. 2Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. 3Department of Tumor Biology, H. Lee Moffitt Cancer ...